MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1α | Zendy

Vincenza Leone | Zendy; Daniela D’Angelo | Zendy; Ileana Gabriela Sanchez Rubio | Zendy; Paula Mussnich de Freitas | Zendy; Antonio Federico | Zendy; Marianna Colamaio | Zendy; Pierlorenzo Pallante | Zendy; Geraldo MedeirosNeto | Zendy; Alfredo Fusco | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1α

Author(s) -

Vincenza Leone,

Daniela D’Angelo,

Ileana Gabriela Sanchez Rubio,

Paula Mussnich de Freitas,

Antonio Federico,

Marianna Colamaio,

Pierlorenzo Pallante,

Geraldo MedeirosNeto,

Alfredo Fusco

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-0345

Subject(s) - thyroid , thyroid carcinoma , cancer research , thyroid cancer , carcinogenesis , stromal cell derived factor 1 , biology , cyclin d2 , cxcr4 , metastasis , stromal cell , papillary thyroid cancer , medicine , cancer , endocrinology , chemokine , cell cycle , receptor , cyclin

Micro-RNA have emerged as an important class of short endogenous RNA that act as posttranscriptional regulators of gene expression and are constantly deregulated in human cancer. MiR-1 has been found down-regulated in lung, colon, and prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research